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Until suitable systemic means are available
for protecting susceptible individuals from the
cumulative damaging effects of excessive ultra-
violet exposure, such protection will be limited
to topically applied sunscreens. There are a
great number of compounds with either physical
or chemical properties which theoretically suggest
their usefulness in this regard. The ultraviolet
absorbing compound must dissipate the absorbed
energy in a harmless manner. Sunscreens were
first made available commercially in 1928, and
since that time many have been introduced.
The ideal sunscreen preparation, according to
Keston, should be hypoallergenic, non-irritating,
non-toxic, and stable (1). It should be cosmetically
acceptable, reasonable in cost, and protect the
skin from about ten times the amount of sunlight
that causes perceptible erythema. For much of
this country, with untanned skin the minimal
erythema dose has been found to approximate
twenty minutes of direct midday June sunlight
(2). According to Daniels' calculations the
M.E.D. for our area should be about 15 minutes
under these conditions (3). Few of the commonly
available sunscreens fulfill these criteria and
no single preparation can be given blanket
approval for universal use
Investigative studies have been carried out in
an effort to evaluate new ultraviolet absorbers
as topical sunscreens. Many of these agents have
originated in industry where they are widely
used as stabilizers to protect fabrics, plastics,
and other materials from photodegradation (4).
A number have been tested and a few found
worthy of more extensive evaluation. Early in-
vestigation by Knox, et al., and several years of
clinical usage, have confirmed the effectiveness
of the benzophenones (5—8). This group, along
along with p-aminobenzoic acid as recommended
by Rothman many years ago (9, 10), and a new
family of compounds, the acrylonitriles, have
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shown superior protective qualities. In addition,
many popular commercial sunscreens and suntan
lotions have been compared. The present study
has been directed towards compounds showing
wide ultraviolet absorption spectra, stability,
and adaptability to dermatologic vehicles.
The objective has been to find a satisfactory
sunscreen which would be of value to patients
with little inherent protection, those most sus-
ceptible to degenerative changes and to light
sensitive dermatoses.
The acryloriitriles are a family of ultraviolet
absorbers of the general formula shown in Chart
I. Their chief industrial use has been to prevent
deterioration of paint and varnish systems as
well as to improve the weatherability of several
types of plastics, particularly polyethylene. The
acrylonitrile most extensively studied by us
has been designated AT 539.f It was selected
over similar compounds because of excellent
solubility and absorption characteristics. It is
soluble in most of the common organic solvents
and its U.V. absorption covers the region where
paint and varnish systems deteriorate. This
coincides with those wavelengths commonly
associated with erythema, sunburn, and car-
cinogenesis.
MATERIALS AND METHODS
Over 100 sunscreening and suntanning formula-
tions were applied to the untanned backs of adult
Caucasian men. They were tested in comparative
series for their ability to prevent artificially in-
duced erythema. An attempt was made to exclude
patients with evidence or history of recent sun-
light exposure, light sensitivity, or medication
that would interfere with testing. Different test
agents were arranged in six vertical strips extend-
ing from the upper scapular areas to the waistline
posteriorly. Whenever possible, agents of compar-
able consistency were used on an individual back.
The substances tested included aerylonitrile,
cinnamate, benzotriazole, benzophenone, and
para-aminobenzoic acid formulations plus a wide
variety of commercially available products.
AT 539, a substituted acrylonitrile, is miscible
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ACRYLONITRILES
GENERAL FORMULA
R ALKYL, ARYL, OR OTHER SUBSTITUENT
CHART I
in all proportions with methanol, ethanol, ethyl
acetate, methyl ethyl ketone, toluene, hexane,
and mineral spirits. It is partially miscible in
ethylene glycol and completely immiscible in
water. The boiling point is 2000 C. (0.1 mm HG)
and the solidification point is —10° C. It does not
react with secondary or tertiary amines but will
react with primary aliphatic amines. It is stable
in bases up to pH 10, and adaptable to many
dermatologic vehicles. The absorption spectrum is
shown in Chart II. The formulations tested most
extensively were prepared 10% and 20% concen-
trations in a vanishing cream base. Ten modifica-
tions of this type were compared.
Commercial lotions and creams tested included
formulations containing 2-ethoxyethyl p-meth-
oxycinnamate, homomenthyl salicylate, menthyl
anthranilate, digalloyl trioleate, and para-amino-benzoic acid esters as the active agent. These
preparations were purchased "over the counter"
at local pharmacies and some popular brands did
not have the active ingredients listed on the label.
The standard benzophenone preparation con-
tained 10% 3-benzoyl-4-hydroxy-6-methoxy hen-
xenesulfonic acid in a vanishing cream base. PABA
was supplied by the hospital pharmacist as a 10%
concentration in the same base as above. Another
formulation contained the same concentration of
the potassium salt of PABA in a different vanish-
ing cream base.
These sunscreens were applied within previously
outlined areas to prevent overlap or mixture with
adjacent compounds. The formulations were ap-
plied as uniformly as possible in a manner simu-
lating normal usage. An adequate strip of un-
treated skin separated the individual test areas.
The patient's back was covered with a small
drape which had thirty-six one inch square holes
arranged in six rows of six each. The vertical rows
were placed so that they coincided with the strip
of sunscreen on the skin beneath. Adjacent ex-
posed skin was covered with appropriate drapes.
Each horizontal row of six holes was covered with
an individual folded towel to permit separate ex-
posure of the entire row without exposing the rows
below.
The source of ultraviolet light was a standard
Hanovia hot quartz mercury vapor lamp (Model
% S-2303A). A fixed distance of 75 cm. from tube to
the patient's back was used in all cases. Irradia-
tion time intervals were varied to determine the
protection afforded by each test formulation. The
minimal erythema dose (M.E.D.) was determined
on many of these patients and it was found to vary
10 to 25 seconds although the average ap-
proximated 15 seconds.
After adjusting the lamp for distance, the
uppermost folded towel was removed exposing the
first horizontal row to ultraviolet energy for a pre-
determined time interval. The next towel was then
removed in like manner and the second row given
an identical exposure. This routine was repeated
in sequence until all six horizontal rows had re-
ceived successively greater times of exposure with
a uniform gradient between each. This procedure
resulted in the upper row receiving six times the
exposure of the lowest row. After removing the
light source and the drapes, the patients were ex-
amined for immediate effects. After twenty-four
hours the results were recorded and photographs
made. The end point was taken as the longest ex-
posure time at which no erythema was observed.
Initially, twenty-second intervals were used for
all new and unknown compounds. This gave
a range of exposures from 20 seconds to 2 minutes
with a 20-second gradient between each successive
exposure. The more effective sunscreens were then
tested on other individuals with increasing ranges
of exposure graduating from a range of one
through six minutes, to two through twelve min-
utes, to five through thirty minutes, and ulti-
mately, for a few superior compounds, a ten
through sixty minute range was utilized. An effort
was made to rotate compounds on successive tests
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from lateral to more medial rows since lateral areas
received slightly less intense irradiation.
EESULTS A
As anticipated in dealing with a large group
of heterogenous compounds, a wide range of
effectiveness was noted.
The 20% acrylonitrile AT 539 in a vanishing
cream base was applied to 32 patients. It pro-
vided complete protection for an average of 9.1
minutes of ultraviolet exposure. This value
corresponds to 36 times the average M.E.D.
and is indicative of excellent protection. The
10% aerylonitrile formulations were not as
efficient. Protection offered in 13 patients
averaged 2.2 minutes or 9 M.E.D.'s. This is,
however, somewhat superior to the average
protection provided by the commercial products
(Chart III).
In general, the protection offered by com-
mercially available products was limited to
prevention of erythema for exposures of only
two minutes or less with the average being about
1 minutes or 6 M.E.D.'s. This finding indicates
that the best currently available commercial
sunscreens are effective for only about 8 times
the M.E.D. and most for only 4 to 6 times the
M.E.D. On rare instances, protection up to 4
minutes was observed on lateral test areas. For
example, six different formulations containing
2-ethoxyethyl-p-methoxycinnamate in concen-
trations ranging from 1.5% to 10% were tested
in 46 patients. Forty individuals received protec-
tion of two minutes or less and only six remained
clear up to the four minute level. The lower
concentrations were effective for only 3 to 4
times the M.E.D. and the vehicle itself would
have provided at least some protection.
There were two pigment-containing commercial
preparations which consistently offered protec-
tion in excess of twelve minutes. One contained
10% 2-benzoyl-4-hydroxy-6-mcthoxy-benzenesul-
fonic acid in a tinted lotion and the other was a
PABA cream with added titanium dioxide. In
spite of their effectiveness, both contained solid
material and lacked some of the qualities
necessary for universal patient acceptance.
PABA (10%) in a vanishing cream base was
effective in excess of twelve minutes' exposure
in 17 patients. In 13 additional patients its
range extended from 20 to 60 minutes. Three-
benzoyl - 4 - hydroxy - 6 - methoxy - benzcnesul-
fonic acid in the same vanishing cream base
provided protection in excess of twelve minutes
on 34 test areas. In nine additional instances it
was effective in the range of 20 to 60 minutes of
exposure. Both agents were superb and essentially
equal in effectiveness.
COMMENT
It is unfortunate that the general public has
the erroneous idea that tanning is associated with
"good health" and "attractiveness." To obtain
suntans many people still deliberately expose
themselves to the sun for prolonged periods of
time. Actually, true tanning is a response to
ultraviolet injury, and the cumulative damage
that results from excessive exposure to sunlight
is the major factor in premature aging (actinie
degeneration) of the skin (11). Also it has been
established that mid-ultraviolet wavelengths of
the solar spectrum are the main causative agents
for skin cancer (12). Natural protection against
these undesirable effects depends largely on
melanin and the stratum corneum. An individual's
natural protection can be easily supplemented
by a suitable topical sunscreen. All of the agents
tested offered some protection although the range
of effectiveness varied greatly.
In such a broad approach to this prob]em,
utilizing many preparations and numerous pa-
tients, the investigators must be aware of a
number of pertinent factors. The concentration
of the active agent, the vehicle, and the thick-
ness of the residual film arc directly related to
the degree of protection offered. Also, individuals
vary in their response. In this study all prepara-
tions were used in a manner simulating normal
usage for it is obviously impossible to apply
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numerous lotions and creams at a uniform thick-
ness with any degree of precision. An alternate
method would be to measure the absorption
characteristics of uniform thin films with a
speetrophotometer. This has the disadvantage
of not taking into consideration possible chemical
and biologic surface phenomena.
A quartz high pressure mercury vapor lamp
does not duplicate the continuous spectrum of
natural sunlight, nor does any available artificial
source. Nevertheless, such lamps are useful for
preliminary screening purposes since the intensity
of U.V. energy is high in the sunburn range (13).
A hot quartz lamp will provide a reliable, constant
output of energy and permit a large number of
tests within a reasonable period of time. Natural
sunlight varies greatly for a variety of reasons
(14). Since sunlight is the final arbitrator, some
of these agents have been tested with natural
sunlight and comparative data gave similar,
although less easy to quantitate, results. During
long exposures sweat elicited by environmental
heat could create an additional variable for
sweat has some absorptive capacity up to the
3300 A range (15). Sweat also has a tendency
to float the protective film away. Although a
hot quartz lamp does produce some heat, sweat-
ing is not of consequence with our testing technic
in an air-conditioned room.
The natural contours of the patient's back
created different angles of incidence and in-
troduced a slight reduction in intensity laterally.
This was compensated in some measure by rotat-
ing agents from lateral to more medial test areas.
Some of the commercial suntan lotions are
elegant formulations with excellent patient ac-
ceptance but minimal protective ability. Many
were easily removed from the skin surface and
appeared to have limited durability. Our current
findings parallel a previous similar evaluation of
twenty-four commercial agents tested on the
skin of shaved albino rabbits (5). Surprisingly,
several routine cosmetics without incorporated
absorbers offered significant protection, and
those containing large amounts of pigment were
quite efficient.
The benzophenone, PABA, and aerylonitrile
preparations were the most effective of all
groups tested. Among the disadvantages noted
with these superior preparations was a tendency
of the benzophenone to be slightly irritating
when applied near the eyes. This appears to be
a pH effect that can be eliminated by buffering.
PABA also may produce irritation, may stain,
and is difficult to formulate into an elegant
preparation when used in higher concentrations.
There are those who might question why
dermatologists should seek ultraviolet absorbers
that provide protection greater than 4 to S
times the M.E.D. level. In this area, midday
sunshine on a clear day in June will produce
erythema in 15 minutes on untanned skin, and
this finding supports the mathematical calcula-
tions of Daniels. The commercially available
formulations, therefore, would protect for only
one to two hours of this type of exposure. Many
individuals, either by necessity or by choice,
subject themselves to much greater exposures.
Also, it should be pointed out that erythema is a
visible response to injury and that repeated
suberythemal injury could be harmful. Subery-
themal doses cannot be regarded as completely
innocuous since histological manifestations prob-
ably could be detected at doses significantly less
than the M.E.D. and ultraviolet injury is
cumulative. The damaging effects of ultraviolet
should be prevented and a satisfactory method
of providing complete or near complete protec-
tion is needed. To be considered excellent a
sunscreen should probably provide protection
for at least 25 times the M.E.D.
In the search for a truly satisfactory absorber
very little attention should be paid to specific
differences in effective concentrations of one
absorbing agent as compared to another. The
goal should be to fulfill the well-defined criteria
relating to safety, efficiency, and patient ac-
ceptance. When sunscreens are commercially
available which meet the necessary standards
it will be up to dermatologists to educate their
patients and the lay public on this subject.
SUMMARY
1. The aerylonitriles, industrial T.J.V. absorbers,
are adaptable for dermatologic purposes as
topical sunscreens.
2. A substituted aerylonitrile (AT 539-Antara
Chemicals) was selected on a basis of solubility
and adsorption spectra for evaluation and com-
parison with other sunsereening compounds.
3. With artificial ultraviolet exposure a 20%
concentration of AT 539 in a vanishing cream
provides an average protection of 36 times the
M.E.D. (Minimal Erythema Dose) for untanned
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human skin. Concentrations of 10% yielded
protection that averaged 9 times the M.E.D.
4. Currently available commercial sunscreen
and suntan preparations are less effective in
preventing erythema with the average protection
being only six times the M.E.D. PABA and
3-benzoyl-4-hydroxy-6-methoxy benzenesulfonie
acid in 10% concentrations give protection for
50 to 100 times the M.E.D.
5. A method for preliminary screening of
potential ultraviolet absorbers is outlined.
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DR. L. C. HARBER, New York, N. Y.: I would
like to compliment the presenters. Certainly
mass testing of topical "sun screening" agents is
necessary for the development of a more satis-
factory means of aetinie protection than is
presently available.
I would like to ask one question. As early as
1941, Blum published studies demonstrating
quantitative differences in the erythema response
at different skin sites in the body (1), and in
similar studies which we performed in guinea-
pigs as well as in humans, a marked difference in
the erythema threshhold between the lower
lumbar area, the scapular and mid-scapular
areas was noted (2). I would like to ask the
presenters if the various compounds being
evaluated were rotated among the skin test
sites so that one would not get a false impression
regarding erythema protection that was actually
due to the higher erythema threshhold skin site
being employed.
DISCUSSION
1. BLUM, H. F.: Photodynamie action and dis-
eases causes by light. Amer. Chem. Soc.
Monograph Series, Reinhold Publ. Corp,
NY, NY, 1941.
2. BAKE, R. L., AND HARBEa, L. C.: Photosensi-
tivity to drugs. Studies in man and guinea
pigs. AMA Arch. Derm., 83: 7—14, 1961.
DR. ROBERT E. Rossar.&N, (in closing): We did
make every effort to rotate these compounds,
realizing that this is only a screening procedure.
Any compound that showed promise whatsoever
was rotated on several patients to other sites.
